CALCITRIOL

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C27H44O3
Molecular Weight	416.6365
Optical Activity	UNSPECIFIED
Defined Stereocenters	6 / 6
E/Z Centers	2
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C3\C[C@@H](O)C[C@H](O)C3=C)[C@H](C)CCCC(C)(C)O

InChI

InChIKey=GMRQFYUYWCNGIN-NKMMMXOESA-N

InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10+,21-11-/t18-,22-,23-,24+,25+,27-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C27H44O3
Molecular Weight	416.6365
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	6 / 6
E/Z Centers	2
Optical Activity	UNSPECIFIED

Description
Sources: http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/21068lbl.pdfhttps://www.ncbi.nlm.nih.gov/mesh/68002117 | https://www.accessdata.fda.gov/drugsatfda_docs/nda/98/021068a_phrmr_P1.pdf
Curator's Comment: description was created based on several sources, including: https://www.drugs.com/cdi/calcitriol.html http://www.wikidoc.org/index.php/Calcitriol_(oral)

Trans-calcitriol or Calcitriol Impurity A, is the impurity of Calcitriol. Calcitriol is the hormonally active form of vitamin D, Calcitriol is the active metabolite of vitamin D3 that activates the vitamin D receptor (VDR). Calcitriol Impurity A is the physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (CALCIFEDIOL). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption.

CNS Activity

Originator

Approval Year

Targets

Primary Target	Pharmacology	Potency
Vitamin D3 receptor 9 Target ID: P11473 Gene ID: 7421.0 Gene Symbol: VDR Target Organism: Homo sapiens (Human) Sources: http://www.drugbank.ca/drugs/DB00136 \| https://www.ncbi.nlm.nih.gov/pubmed/10517670	Binding Agent 1059	0.22 nM [Kd]
Cytochrome P450 24A1 6 Target ID: CHEMBL4521 Sources: http://www.drugbank.ca/drugs/DB00136 \| https://www.ncbi.nlm.nih.gov/pubmed/16207822 Ahn, J. et al. (2016) 'Vitamin D Hormone', p.327 Retrieved from \| https://books.google.ru/books?id=-OSECgAAQBAJ	Substrate 656
Cytochrome P450 3A4 126 Target ID: CHEMBL340 Sources: http://www.drugbank.ca/drugs/DB00136 \| https://www.ncbi.nlm.nih.gov/pubmed/16207822	Substrate 656

Conditions

Condition	Modality	Highest Phase	Product
Unknown 2565
Secondary hyperparathyroidism 9 Sources: http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/21068lbl.pdf	Primary	Approved 8360	ROCALTROL Approved Use Predialysis Patients Calcitriol Capsules are indicated in the management of secondary hyperparathyroidism and resultant metabolic bone disease in patients with moderate to severe chronic renal failure (Ccr 15 to 55 mL/min) not yet on dialysis. In children, the creatinine clearance value must be corrected for a surface area of 1.73 square meters. A serum iPTH level of ≥100 pg/mL is strongly suggestive of secondary hyperparathyroidism. Dialysis Patients Calcitriol Capsules are indicated in the management of hypocalcemia and the resultant metabolic bone disease in patients undergoing chronic renal dialysis. In these patients, calcitriol administration enhances calcium absorption, reduces serum alkaline phosphatase levels, and may reduce elevated parathyroid hormone levels and the histological manifestations of osteitis fibrosa cystica and defective mineralization. Hypoparathyroidism Patients Calcitriol Capsules are also indicated in the management of hypocalcemia and its clinical manifestations in patients with postsurgical hypoparathyroidism, idiopathic hypoparathyroidism, and pseudohypoparathyroidism. Launch Date 2.72159998E11
Hypocalcemia 75 Sources: http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/21068lbl.pdf	Preventing	Approved 8360	ROCALTROL Approved Use Predialysis Patients Calcitriol Capsules are indicated in the management of secondary hyperparathyroidism and resultant metabolic bone disease in patients with moderate to severe chronic renal failure (Ccr 15 to 55 mL/min) not yet on dialysis. In children, the creatinine clearance value must be corrected for a surface area of 1.73 square meters. A serum iPTH level of ≥100 pg/mL is strongly suggestive of secondary hyperparathyroidism. Dialysis Patients Calcitriol Capsules are indicated in the management of hypocalcemia and the resultant metabolic bone disease in patients undergoing chronic renal dialysis. In these patients, calcitriol administration enhances calcium absorption, reduces serum alkaline phosphatase levels, and may reduce elevated parathyroid hormone levels and the histological manifestations of osteitis fibrosa cystica and defective mineralization. Hypoparathyroidism Patients Calcitriol Capsules are also indicated in the management of hypocalcemia and its clinical manifestations in patients with postsurgical hypoparathyroidism, idiopathic hypoparathyroidism, and pseudohypoparathyroidism. Launch Date 2.72159998E11
Mild to moderate plaque psoriasis 4 Sources: http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022087lbl.pdf	Primary	Approved 8360	VECTICAL Approved Use VECTICAL Ointment is indicated for the topical treatment of mild to moderate plaque psoriasis in adults 18 years and older. Launch Date 2.72159998E11

C_max

Value	Dose	Co-administered	Analyte	Population
1100 pg/mL EXPERIMENT https://www.ncbi.nlm.nih.gov/pubmed/12496746	38 μg 3 times / week multiple, oral dose: 38 μg route of administration: Oral experiment type: MULTIPLE co-administered: PACLITAXEL	PACLITAXEL	CALCITRIOL plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN
73.1799999999999 pg/mL Clinical Trial https://clinicaltrials.gov/ct2/show/NCT00419666	3 ug/g 2 times / day multiple, topical dose: 3 ug/g route of administration: topical experiment type: multiple co-administered:		CALCITRIOL plasma	Homo sapiens population: unhealthy age: Adolescents sex: F+M food status:
75.74 pg/mL Clinical Trial https://clinicaltrials.gov/ct2/show/NCT00419666	3 ug/g single, topical dose: 3 ug/g route of administration: topical experiment type: single co-administered:		CALCITRIOL plasma	Homo sapiens population: unhealthy age: Adolescents sex: F+M food status:

AUC

Value	Dose	Co-administered	Analyte	Population
8100 pg × h/mL EXPERIMENT https://www.ncbi.nlm.nih.gov/pubmed/12496746	38 μg 3 times / week multiple, oral dose: 38 μg route of administration: Oral experiment type: MULTIPLE co-administered: PACLITAXEL	PACLITAXEL	CALCITRIOL plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN
737.74 pg*h/mL Clinical Trial https://clinicaltrials.gov/ct2/show/NCT00419666	3 ug/g 2 times / day multiple, topical dose: 3 ug/g route of administration: topical experiment type: multiple co-administered:		CALCITRIOL plasma	Homo sapiens population: unhealthy age: Adolescents sex: F+M food status:
764.74 pg*h/mL Clinical Trial https://clinicaltrials.gov/ct2/show/NCT00419666	3 ug/g single, topical dose: 3 ug/g route of administration: topical experiment type: single co-administered:		CALCITRIOL plasma	Homo sapiens population: unhealthy age: Adolescents sex: F+M food status:
549.29 pg*h/mL Clinical Trial https://clinicaltrials.gov/ct2/show/NCT00419666	3 ug/g 2 times / day multiple, topical dose: 3 ug/g route of administration: topical experiment type: multiple co-administered:		CALCITRIOL plasma	Homo sapiens population: unhealthy age: Adolescents sex: F+M food status:
575.12 pg*h/mL Clinical Trial https://clinicaltrials.gov/ct2/show/NCT00419666	3 ug/g single, topical dose: 3 ug/g route of administration: topical experiment type: single co-administered:		CALCITRIOL plasma	Homo sapiens population: unhealthy age: Adolescents sex: F+M food status:

T_1/2

Value	Dose	Co-administered	Analyte	Population
25 h EXPERIMENT https://www.ncbi.nlm.nih.gov/pubmed/12496746	38 μg 3 times / week multiple, oral dose: 38 μg route of administration: Oral experiment type: MULTIPLE co-administered: PACLITAXEL	PACLITAXEL	CALCITRIOL plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN

Sourcing

Vendor/Aggregator	ID	URL
AHH Chemical co.,ltd	NP-1040	http://www.ahhchemical.com/product/NP-1040.html
AbMole Bioscience	M2174	http://www.abmole.com/products/calcitriol.html
Achemo Scientific Limited	AC-16679	http://www.achemo.com/search/?Keyword= 32222-06-3
Achemtek	0101-001973	http://www.achemtek.com/32222-06-3
Alfa Chemistry	AP32222063-C	https://reagents.alfa-chemistry.com/product/1-25-dihydroxyvitamin-d3-cas-32222-06-3-9957.html
Alfa Chemistry	AP32222063-A	https://reagents.alfa-chemistry.com/product/1-25-dihydroxyvitamin-d3-solution-cas-32222-06-3-9955.html
Alfa Chemistry	AP32222063-B	https://reagents.alfa-chemistry.com/product/calcitriol-solution-cas-32222-06-3-9956.html
Alfa Chemistry	32222-06-3	https://www.alfa-chemistry.com/calcitriol-cas-32222-06-3-item-291485.htm
Alsachim	1921	http://www.alsachim.com/product-C2847-glo.bal-view.html
ApexBio Technology	B2141	http://www.apexbt.com/calcitriol.html
Aurora Fine Chemicals LLC	A17.877.497	http://online.aurorafinechemicals.com/info?ID=A17.877.497
Aurora Fine Chemicals LLC	K02.111.135	http://online.aurorafinechemicals.com/info?ID=K02.111.135
Aurum Pharmatech LLC	W-5161	http://www.Aurumpharmatech.com/Product/ProductDetails/W_5161
AvaChem Scientific	2191	http://www.avachem.com/productSearch.asp?2191
BLD Pharm	BD01358017	http://www.bldpharm.com/products/1000873-74-4.html
BioCrick	BCC4950	http://www.biocrick.com/Calcitriol-BCC4950.html
Boerchem	BC208534	http://www.boerchem.com/?product_35283.html
Calbiochem	679101	http://www.emdbiosciences.com/product/679101
Capot Chemical	18818	http://www.capotchem.com/en/18818.htm
Capot Chemical	PubChem18818	http://www.capotchem.com/en/18818.htm
Capot Chemical	19327	http://www.capotchem.com/en/19327.htm
Capot Chemical	PubChem19327	http://www.capotchem.com/en/19327.htm
Chem Scene	CS-0388	http://www.chemscene.com/32222-06-3.html
ChemMol	30104349	http://www.chemmol.com/chemmol/30104349.html
ChemMol	44003293	http://www.chemmol.com/chemmol/44003293.html
ChemMol	49408407	http://www.chemmol.com/chemmol/49408407.html
ChemMol	99070257	http://www.chemmol.com/chemmol/99070257.html
Chemspace	CSSB00020610488	https://chem-space.com/CSSB00020610488
Chiralblock Biosciences	CB11406	http://www.chiralblock.com/products/32222-06-3.html
Clearsynth	CS-O-06153	https://www.clearsynth.com/en/CSO06153.html
EMD Millipore	679101	http://www.emdbiosciences.com/product/679101
Excenen	EX-A4435	https://www.excenen.com/searchresultlist.php?id=EX-A4435
Glentham Life Sciences	GP9482	http://www.glentham.com/products/product/GP9482/
Hello Bio	HB3962	http://www.hellobio.com/luteolin-5897.html
LGC Standards	DRE-A10934950AL-100	https://www.lgcstandards.com/US/en/p/DRE-A10934950AL-100
LGC Standards	DRE-C10934950	https://www.lgcstandards.com/US/en/p/DRE-C10934950
LGC Standards	MM0205.00	https://www.lgcstandards.com/US/en/p/MM0205.00
Lab Network	LN01276594	https://labnetwork.com/frontend-app/p/#!/moleculedetails/LN01276594
Matrix Scientific	144307	https://www.matrixscientific.com/144307.html
MedChem Express	HY-10002	https://www.medchemexpress.com/Calcitriol.html
MuseChem	A000862	https://www.musechem.com/product/A000862.html
OChem	1562	http://www.ocheminc.com/index.php?act=psearch&pid=222C063
Parchem	28433	http://www.parchem.com/chemical-supplier-distributor/Calcitriol-018433.aspx
Selleck Chemicals	S1466	http://www.selleckchem.com/products/Calcitriol-(Rocaltrol).html
Sigma-Aldrich	C0225000_SIAL	https://www.sigmaaldrich.com/catalog/product/sial/c0225000?utm_source=pubchem&utm_campaign=pubchem_2017&utm_medium=referral
Sigma-Aldrich	17936_SIGMA	https://www.sigmaaldrich.com/catalog/product/sigma/17936?utm_source=pubchem&utm_campaign=pubchem_2017&utm_medium=referral
Sigma-Aldrich	D1530_SIGMA	https://www.sigmaaldrich.com/catalog/product/sigma/d1530?utm_source=pubchem&utm_campaign=pubchem_2017&utm_medium=referral
Smolecule	S800501	https://www.smolecule.com/products/s800501
Sun-shine Chemical	Calcitriol	http://sun-shinechem.com/
TCI (Tokyo Chemical Industry)	C3078	http://www.tcichemicals.com/eshop/en/us/commodity/C3078/index.html
Tocris	2551	https://www.tocris.com/products/calcitriol_2551
VladaChem	VL266434-2.5mg	https://www.vladachem.com/product.php?products=32222-06-3
Yuhao Chemical	LT7054	http://www.chemyuhao.com/32222-06-3.html
abcr GmbH	AB465093	http://www.abcr.com/shop/en/AB465093
eNovation Chemicals	D371145	http://www.enovationchem.com/productDetails.asp?productID=D371145
eNovation Chemicals	Y0974280	https://www.enovationchem.com/ProductDetails.asp?ProductID=Y0974280
iChemical	EBD646297	http://www.ichemical.com/products/32222-06-3.html?utm_source=PubChem&utm_medium=website&utm_campaign=product%20catalogs

PubMed

Title	Date	PubMed
Effect of 1,25-dihydroxyvitamin D3 on the female reproductive system in rats.	1992 Aug	1453499
Potentiation of lipopolysaccharide-induced tumor necrosis factor-alpha expression by 1,25-dihydroxyvitamin D3.	1992 Dec 1	1450407
Hypercalcemia-induced renal insufficiency during therapy with dihydrotachysterol.	1999	10515239
Effectiveness of 1,25-dihydroxyvitamin D supplementation on blood pressure reduction in a pseudohypoparathyroidism patient with high renin activity.	1999 Jan	10052739
Antineoplastic effect and toxicity of 1,25-dihydroxy-16-ene-23-yne-vitamin D3 in athymic mice with Y-79 human retinoblastoma tumors.	1999 Mar	10088815
22-oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure.	1999 Mar	10027919
A new concept of tumor promotion by tumor necrosis factor-alpha, and cancer preventive agents (-)-epigallocatechin gallate and green tea--a review.	2000	10757128
Zinc increases the activity of vitamin D-dependent promoters in osteoblasts.	2000 Apr 29	10777672
Vitamin K(2) inhibits adipogenesis, osteoclastogenesis, and ODF/RANK ligand expression in murine bone marrow cell cultures.	2000 Dec	11113387
Association of transforming growth factor beta1 genotype with therapeutic response to active vitamin D for postmenopausal osteoporosis.	2000 Mar	10750555
Regulation of vitamin D-1alpha-hydroxylase and -24-hydroxylase expression by dexamethasone in mouse kidney.	2000 Mar	10694374
24,25-dihydroxyvitamin D3 in combination with 1,25-dihydroxyvitamin D3 ameliorates renal osteodystrophy in rats with chronic renal failure.	2000 May	11305809
Comparison of the relative effects of 1,24-dihydroxyvitamin D(2) [1, 24-(OH)(2)D(2)], 1,24-dihydroxyvitamin D(3) [1,24-(OH)(2)D(3)], and 1,25-dihydroxyvitamin D(3) [1,25-(OH)(2)D(3)] on selected vitamin D-regulated events in the rat.	2000 Sep 1	10927029
Effects of 1alpha,25-(OH)(2)D(3) on rat growth zone chondrocytes are mediated via cyclooxygenase-1 and phospholipase A(2).	2001	11455568
Beneficial effect of 1,25 dihydroxyvitamin D3 on cytokine-treated human pancreatic islets.	2001 Apr	11250657
Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3.	2001 Dec	11723248
1,25(OH)2 vitamin D3 induces elevated expression of the cell cycle-regulating genes P21 and P27 in squamous carcinoma cell lines of the head and neck.	2001 Jan	11270487
Mepe, the gene encoding a tumor-secreted protein in oncogenic hypophosphatemic osteomalacia, is expressed in bone.	2001 Jun 15	11414762
Failure of high doses of calcitriol and hypercalcaemia to induce apoptosis in hyperplastic parathyroid glands of azotaemic rats.	2001 Mar	11239023
Dietary phosphorus deprivation induces 25-hydroxyvitamin D(3) 1alpha-hydroxylase gene expression.	2001 May	11316734
Regression of ventral striatum hypometabolism after calcium/calcitriol therapy in paroxysmal kinesigenic choreoathetosis due to idiopathic primary hypoparathyroidism.	2001 Nov	11606688
Mediation of unusually high concentrations of 1,25-dihydroxyvitamin D in homozygous klotho mutant mice by increased expression of renal 1alpha-hydroxylase gene.	2002 Feb	11796525
Apoptosis induction by 1alpha,25-dihydroxyvitamin D3 in prostate cancer.	2002 Jul	12479363
Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D.	2002 Jul	12089348
Does melatonin induce apoptosis in MCF-7 human breast cancer cells in vitro?	2002 Mar	12071473
HL60 cells halted in G1 or S phase differentiate normally.	2002 Nov 15	12441127
Demonstration of UVB-induced synthesis of 1 alpha,25-dihydroxyvitamin D3 (calcitriol) in human skin by microdialysis.	2003 Apr	12709817
Gene expression of vitamin D hydroxylase and megalin in the remnant kidney of nephrectomized rats.	2003 Aug	12846736
9-cis retinoic acid accelerates calcitriol-induced osteocalcin production and promotes degradation of both vitamin D receptor and retinoid X receptor in human osteoblastic cells.	2003 Aug 15	12898515
Comparison of the gene expression profiles of monocytic versus granulocytic lineages of HL-60 leukemia cell differentiation by DNA microarray analysis.	2003 Aug 15	12875902
Previtamin D3 with a trans-fused decalin CD-ring has pronounced genomic activity.	2003 Sep 12	12829710
Unique regulation of SOST, the sclerosteosis gene, by BMPs and steroid hormones in human osteoblasts.	2004 Aug	15268896
Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.	2004 Aug	15264182
Calcitriol-induced prostate-derived factor: autocrine control of prostate cancer cell growth.	2004 Dec 20	15386353
Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis.	2004 Jul 8	15138306
Improved anemia and reduced erythropoietin need by medical or surgical intervention of secondary hyperparathyroidism in hemodialysis patients.	2004 May	15354979
The functional consequences of cross-talk between the vitamin D receptor and ERK signaling pathways are cell-specific.	2004 Nov 5	15331595
Calcium and calcitriol prophylaxis attenuates posttransplant bone loss.	2004 Oct 27	15502727
Role of uncoupling protein 2 (UCP2) expression and 1alpha, 25-dihydroxyvitamin D3 in modulating adipocyte apoptosis.	2004 Sep	15231722
Modulation of CYP27B1 and CYP24 mRNA expression in bone is independent of circulating 1,25(OH)2D3 levels.	2005 Apr	15781002
Molecular and functional comparison of 1,25-dihydroxyvitamin D(3) and the novel vitamin D receptor ligand, lithocholic acid, in activating transcription of cytochrome P450 3A4.	2005 Apr 1	15578590
1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.	2005 Feb	15647825
Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative.	2005 Jan	15489543
Type 2 iodothyronine selenodeiodinase is expressed throughout the mouse skeleton and in the MC3T3-E1 mouse osteoblastic cell line during differentiation.	2005 Jan	15471965
Regulation of the human vitamin D3 receptor promoter in breast cancer cells is mediated through Sp1 sites.	2005 Jan 31	15664452
Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells.	2005 Jun	15671080
Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats.	2005 Mar	15746989
Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients.	2005 Mar	15698453
Regulation of renal calcium receptor gene expression by 1,25-dihydroxyvitamin D3 in genetic hypercalciuric stone-forming rats.	2005 May	15788476
Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.	2005 Sep 1	15754350

Patents

Sample Use Guides

In Vivo Use Guide

Calcitriol can be administered orally either as a capsule (0.25 mcg or 0.50 mcg) or as an oral solution (1 mcg/mL).

Route of Administration: Other

In Vitro Use Guide

CYP3A4 mRNA expression in LS180 cells treated with 100 nM of Calcitriol for 6 and 24 h was approximately 80- and 500-fold higher than the control.

Substance Class	Chemical Created by `admin` on `Wed Jul 05 23:16:38 UTC 2023` Edited by `admin` on `Wed Jul 05 23:16:38 UTC 2023`
Record UNII	FXC9231JVH
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CALCITRIOL

Official Name

English

CALCITRIOL [MART.]

Common Name

English

VECTICAL

Brand Name

English

CALCITRIOL [VANDF]

Common Name

English

ROCALTROL

Brand Name

English

CALCIJEX

Brand Name

English

CALCITRIOL [USP MONOGRAPH]

Common Name

English

CALCITRIOL [EP MONOGRAPH]

Common Name

English

(1S,3R,5Z,7E)-9,10-SECOCHOLESTA-5,7,10-TRIENE-1,3,25-TRIOL

Common Name

English

CALCITRIOL [USP-RS]

Common Name

English

RO-21-5535

Code

English

CALCITRIOL [JAN]

Common Name

English

RO-215535

Code

English

Calcitriol [WHO-DD]

Common Name

English

CALCITRIOL [HSDB]

Common Name

English

CALCITRIOL [ORANGE BOOK]

Common Name

English

calcitriol [INN]

Common Name

English

1,25-DIHYDROXY VITAMIN D3

Common Name

English

1,25-HYDROXYLATED VITAMIN D

Common Name

English

1,25-DIHYDROXYVITAMIN D3

Common Name

English

RO 21-5535

Code

English

CALCITRIOL [USAN]

Common Name

English

CALCITRIOL [MI]

Common Name

English

9,10-SECOCHOLESTA-5,7,10(19)-TRIENE-1,3,25-TRIOL, (1.ALPHA.,3.BETA.,5Z,7E)-

Common Name

English

(5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1α,3β,25-triol

Common Name

English

1,25-DIHYDROXYCHOLECALCIFEROL, (1ALPHA)-

Common Name

English

Classification Tree Code System Code

NDF-RT

N0000006996